this Murcia region will work with the other three autonomous regions, Evaluation of a hepatitis B screening program during pregnancy As well as the early management of newborns, local government sources said in a statement.
With this study, not only screening for hepatitis B during pregnancy was assessed, but also whether newborn sons of mothers with hepatitis B were correctly following the course of action as it was necessary at birth Get vaccinated within the first few hours of their life And specific immunoglobulins are administered to prevent mother-to-child transmission of infection.
Hepatitis B Screening During Pregnancy It has been established in the region since 1994 Included in the Integrated Women’s Care Program (PIAM) since 2012. Most pregnant women are included in the SMS pregnancy surveillance program and at any time during their adhering pregnancy, are screened for this and take appropriate measures to avoid vertical transmission.
According to data recorded by the Vaccine Service, the region’s public maternity hospitals have a 100 percent compliance rate for the operation.
According to data recorded by the Vaccine Service, the region’s public maternity hospitals are 100% operationally compliant as all babies born to carrier mothers in 2021 and 2022 will be vaccinated against gamma globulin and hepatitis B before leaving the hospital vaccine. Hospital.
As part of a strategy to eliminate hepatitis B, WHO urges countries to deepen their evaluation of hepatitis B screening programs in pregnancy and early childhood management.
The Ministry of Health will start evaluating this screening at the national level and select the Community to conduct a study with Madrid, Valencia and Catalonia. In this study, vaccination data from the Regional Vaccination Registry have been included, as well as data from the perinatal clinical history of the Region of Murcia, which was awarded the National Health System Good Practice Award in 2020.
More than two billion worldwide
this World Health Organization (World Health Organization) estimates that the global More than 2 billion people are infected with the hepatitis B virus, Of these, 240 million suffer from chronic infections. Hepatitis B is a vaccine-preventable disease. The vaccine was introduced in adolescents in the 1990s, and the age at which vaccinations began was lowered to one year of age in 1999.
Neonates with mother-to-child transmission of infection during delivery have a 90% probability of chronic HBV infection.
Current hepatitis B vaccination coverage in my country More than 95% of the child population, As a result, most adults under the age of 40 have been vaccinated against hepatitis B, and the incidence has dropped significantly, with the current Spain is considered a country with a low prevalence. According to the regional administration, coverage is slightly higher in the Murcia region.
However, the severity and chronicity of the disease are inversely proportional to the age at onset. In fact, the probability of chronic HBV infection in neonates infected with mother-to-child transmission during delivery is 90%. Elimination of mother-to-child transmission of this HBV infection is therefore considered a milestone on the road to elimination.